Search News Archives
VIEW THE LATEST ISSUE
Microscopy | Image Analysis
IT Solutions and Laboratory Automation
Conferences | Events
Royal Visit for Malvern Panalytical to celebrate key role in vaccine development
Malvern Panalytical, analytical systems manufacturer and contract services provider, was delighted to welcome His Royal Highness The Earl of Wessex to its Malvern, Worcestershire, headquarters.
Malvern Panalytical was selected for the Royal visit, amongst a small number of other Worcestershire businesses, primarily because of its scientific and technical contribution to the development of medicines and vaccines to treat and prevent COVID-19.
Andrew Heath – Chief Executive, Spectris plc, stated: “It has been our pleasure to welcome Prince Edward to our Malvern development and manufacturing facility and to explain how Malvern Panalytical’s people, products and services are assisting the global effort to fight COVID-19. We are immensely proud of the role the team here is playing in applying its technical and scientific expertise to help alleviate this humanitarian crisis.”
His Royal Highness was introduced to a number of Malvern Panalytical employees from across the business during his walk through the facility, learning about the roles they play in the development of new technologies and services. Also on display were a number of the scientific instruments used by Malvern Panalytical’s pharmaceutical customers in developing and manufacturing new drugs and vaccines, including the Zetasizer Advance light scattering range, Morphologi 4 analytical imaging systems, OMNISEC size exclusion chromatography instruments and NanoSight nanoparticle tracking analysis platforms.
The vital role science has played in the fight against COVID-19 is clear. Malvern Panalytical is proud to play a key role in the global effort to develop treatments and vaccines, providing analytical instruments and expert support to SARS-CoV-2 vaccine labs across the globe.
Mark Fleiner - President, Malvern Panalytical, commented: “Throughout 2020 and 2021, we have witnessed our analytical systems and services make a real contribution to the development of protein antigen and mRNA-based COVID-19 vaccines, as well as to the development of antiviral drugs. Malvern Panalytical provides the instruments and expertise to support robust and rapid vaccine development and assist pharmaceutical organizations in assuring the quality of vaccines and other treatments.”
“It makes us proud to see how we are helping our customers create a better world in all sorts of markets. From renewable energy and sustainable building materials, all the way through to nutritious foods and critically important medicines, Malvern Panalytical is making a positive impact.”
About Malvern Panalytical
Malvern Panalytical harnesses the power of its high-precision analytical instruments to make the invisible visible and the impossible possible. Through the chemical, physical and structural analysis of materials, our analytical systems and services equip our customers to create a better world, helping them to improve everything from the energies that power us and the materials we build with, to the medicines that cure us and the foods we enjoy. We partner with many of the world’s biggest companies, universities and research organizations. Our customers value us not only for the power of our solutions, but also for the depth of our expertise, collaboration and integrity. With over 2200 employees, we serve the world, and we are part of Spectris plc, the world-leading precision measurement group. Malvern Panalytical. we’re BIG on small ™.